Full article view2018-09-26T10:56:18+00:00

Drugmakers need to focus on how a drug improves total patient health

 

In an article in Managed Care, Jeremy Schafer discusses the findings from a recent breast cancer study reported in JAMA. The results help to validate that emerging drug therapies have played an important role in the declining mortality rates. However, health care stakeholders need to encourage utilization of treatments to deliver the best outcomes.

To read the full article, please click here.

 

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

What kind of expertise do you need?





By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.

OK